Phase 2 Trial of Obinutuzumab and CC-99282 for Patients with Untreated High Tumor Burden Follicular Lymphoma | Clinical Trial

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients with Untreated High Tumor Burden Follicular Lymphoma | Clinical Trial | Right2Hope